康华生物,300841,收入构成,报告日期,2021-06-30, 按地域,收入(万元),成本(万元),利润(万元),毛利率,利润占比 西南,4252,-- ,4252,--,7.59% 西北,3473,-- ,3473,--,6.2% 境外,5,-- ,5,--,0.01% 华中,8751,-- ,8751,--,15.62% 华南,5509,-- ,5509,--,9.83% 华东,19672,-- ,19672,--,35.1% 华北,12291,-- ,12291,--,21.93% 东北,2087,-- ,2087,--,3.72% 康华生物,300841,收入构成,报告日期,2020-12-31, 按地域,收入(万元),成本(万元),利润(万元),毛利率,利润占比 西南,9600,791,8810,91.77%,9.03% 西北,5646,308,5338,94.54%,5.47% 境外,286,101,185,64.64%,0.19% 华中,15734,974,14760,93.81%,15.13% 华南,9034,544,8491,93.98%,8.7% 华东,41087,2361,38726,94.25%,39.69% 华北,17534,930,16604,94.7%,17.02% 东北,4940,276,4665,94.42%,4.78% 康华生物,300841,收入构成,报告日期,2020-03-31, 按地域,收入(万元),成本(万元),利润(万元),毛利率,利润占比 华北,2206,84,2122,96.2%,14.08% 西南,1710,70,1640,95.92%,10.88% 东北,1231,51,1180,95.85%,7.83% 华中,2009,84,1925,95.84%,12.77% 西北,857,32,825,96.28%,5.48% 华南,1915,76,1839,96.03%,12.2% 华东,5782,240,5542,95.85%,36.76% 康华生物,300841,收入构成,报告日期,2019-12-31, 按地域,收入(万元),成本(万元),利润(万元),毛利率,利润占比 西南,2305,159,2146,93.09%,4.11% 华东,24159,1402,22757,94.2%,43.57% 东北,2289,116,2174,94.95%,4.16% 其他(补充),8,1,8,92.95%,0.02% 西北,2846,136,2709,95.21%,5.19% 华中,9414,593,8821,93.7%,16.89% 境外,129,92,37,28.39%,0.07% 华南,4656,225,4431,95.17%,8.48% 华北,9656,510,9146,94.72%,17.51% 康华生物,300841,收入构成,报告日期,2018-12-31, 按地域,收入(万元),成本(万元),利润(万元),毛利率,利润占比 华北,12241,644,11597,94.74%,21.95% 华南,4210,216,3995,94.87%,7.56% 华中,11400,612,10789,94.64%,20.42% 其他(补充),2,-- ,2,--,0% 西北,1770,79,1691,95.53%,3.2% 东北,1999,104,1895,94.82%,3.59% 西南,2353,166,2187,92.93%,4.14% 华东,21858,1199,20659,94.51%,39.1% 境外,113,90,23,20.49%,0.04% 康华生物,300841,收入构成,报告日期,2017-12-31, 按地域,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),6,0,6,98.79%,0.02% 西北,131,13,118,89.79%,0.5% 华中,6023,596,5427,90.1%,23.16% 西南,1263,171,1092,86.49%,4.66% 境外,103,84,20,19.05%,0.08% 华南,2651,340,2311,87.18%,9.86% 华北,3231,310,2921,90.4%,12.47% 华东,12115,1178,10937,90.28%,46.68% 东北,671,70,601,89.57%,2.56%